These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 13196179)

  • 1. [Endocrine therapy of prostate cancer 1945-47].
    BOJSEN F
    Ugeskr Laeger; 1954 Jul; 116(27):1010-4. PubMed ID: 13196179
    [No Abstract]   [Full Text] [Related]  

  • 2. [Secondary cancer of the lung of prostatic origin; recovery maintained for 3 years by diethylstilbestrol therapy].
    MEYER A; LIOT F
    Bull Mem Soc Med Hop Paris; 1954 Mar 26-Apr 9; 70(11-12):401-4. PubMed ID: 13172629
    [No Abstract]   [Full Text] [Related]  

  • 3. Endocrine inhibition as related to carcinoma of the prostate.
    VALK WL; OWENS RH
    Trans South Cent Sect Am Urol Assoc; 1953; 48():55-65. PubMed ID: 13187581
    [No Abstract]   [Full Text] [Related]  

  • 4. [Metastatic prostate cancer. High-dose diethylstilbestrol and hormonal escape].
    Chaouat D; Court B
    Rev Rhum Ed Fr; 1994 Apr; 61(4):290. PubMed ID: 7920531
    [No Abstract]   [Full Text] [Related]  

  • 5. Carcinoma of the prostate: delayed endocrine therapy is best.
    Cockburn AG
    Semin Urol; 1983 Nov; 1(4):280-7. PubMed ID: 6399614
    [No Abstract]   [Full Text] [Related]  

  • 6. [Secondary endocrine therapy with oral estrogen for relapsed prostate cancer].
    Onita T; Igawa T; Hisamatsu H; Sakai H; Kanetake H
    Hinyokika Kiyo; 2009 Oct; 55(10):595-8. PubMed ID: 19926941
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Estrogen therapy in carcinoma of the prostate.
    BIRKE G; FRANKSSON C; PLANTIN LO
    Acta Chir Scand; 1955 Apr; 109(1):1-10. PubMed ID: 14387447
    [No Abstract]   [Full Text] [Related]  

  • 8. [Preliminary report on oral honvan therapy of prostate carcinoma].
    WARNECKE CE
    Medizinische; 1957 Nov; 25(44):1625-7. PubMed ID: 13492945
    [No Abstract]   [Full Text] [Related]  

  • 9. Re: Enhancement of diethylstilbestrol induced cytotoxicity by bcl-2 antisense oligodeoxynucleotides and a glutathione depletor for prostate cancer.
    Pitts WR
    J Urol; 2003 Nov; 170(5):1954; author reply 1954-5. PubMed ID: 14532826
    [No Abstract]   [Full Text] [Related]  

  • 10. Mammary neoplasm in a male receiving oestrogen therapy for carcinoma of the prostate.
    MOULTON JE
    Med J Aust; 1959 May; 1(21):706-7. PubMed ID: 13666165
    [No Abstract]   [Full Text] [Related]  

  • 11. The nonsteroidal effects of diethylstilbestrol: the rationale for androgen deprivation therapy without estrogen deprivation in the treatment of prostate cancer.
    Scherr DS; Pitts WR
    J Urol; 2003 Nov; 170(5):1703-8. PubMed ID: 14532759
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Comparative studies on the side-effects of estrogen therapy in the use of various types of hormones in patients with prostate carcinoma & adenoma].
    TAUPITZ A
    Medizinische; 1959 May; 4(18):873-6. PubMed ID: 13656334
    [No Abstract]   [Full Text] [Related]  

  • 13. Endocrine therapy in the management of prostatic cancer.
    HECKEL NJ
    J Clin Endocrinol Metab; 1953 Feb; 13(2):228-30. PubMed ID: 13034908
    [No Abstract]   [Full Text] [Related]  

  • 14. Planned cytostatic therapy of carcinoma of the prostate.
    WARNECKE CE
    Bruns Beitr Klin Chir; 1955 May; 190(3):341-8. PubMed ID: 14389781
    [No Abstract]   [Full Text] [Related]  

  • 15. [Results of conservative therapy in prostate carcinoma].
    PAGEL W
    Z Urol; 1957; 50(12):681-8. PubMed ID: 13531567
    [No Abstract]   [Full Text] [Related]  

  • 16. Re-induction of hormone sensitivity to diethylstilboestrol in androgen refractory prostate cancer patients following chemotherapy.
    Cox RA; Sundar S
    Br J Cancer; 2008 Jan; 98(1):238-9. PubMed ID: 18182981
    [No Abstract]   [Full Text] [Related]  

  • 17. [New treatments for cancer of the prostate].
    AMIEL C
    Vie Med; 1959 Apr; 40(4):337 passim. PubMed ID: 13659813
    [No Abstract]   [Full Text] [Related]  

  • 18. Population based study of hormonal therapy and survival in men with metastatic prostate cancer.
    Lu-Yao G; Moore DF; Oleynick JU; DiPaola RS; Yao SL
    J Urol; 2007 Feb; 177(2):535-9. PubMed ID: 17222628
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Effects of stilbo-estrol phosphate in prostate carcinoma].
    HOHLWEG W; GROOT-WASSINK KA
    Dtsch Gesundheitsw; 1959 Jan; 14(4):152-7. PubMed ID: 13639631
    [No Abstract]   [Full Text] [Related]  

  • 20. [Organ-specific chemotherapy of carcinoma of the prostate].
    BUDNIOK R; STOLL HG; ALTVATER G
    Dtsch Med Wochenschr; 1955 Jan; 80(4):143-6. PubMed ID: 14352775
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.